Skip to main content

Table 5 Possible predictive factors in univariate and multivariate analysis

From: Definitive external-beam radiotherapy versus radical prostatectomy in clinically localized high-risk prostate cancer: a retrospective study

 

OR

95% CI

p

All patients-univariate

 Age

0.96

0.92–1.00

0.066+

 PSA ≥20 ng/mL

1.26

0.66–2.41

0.480

 Clinical ≥T3 stage

0.70

0.35–1.41

0.319

 GS ≥8 at biopsy

1.29

0.69–2.42

0.430

 Treatment group RP

4.61

2.36–9.00

< 0.001*

All patients-multivariate

 PSA ≥20 ng/mL

1.85

0.95–3.59

0.069+

 Treatment group RP

5.35

2.69–10.61

< 0.001*

ExRT group-univariate

 ADT use < 2-year

1.98

0.72–5.49

0.188

 No PLI

2.53

0.93–6.91

0.071+

ExRT group-multivariate

 ADT use < 2-year

2.42

0.85–6.89

0.098

 No PLI

2.87

1.01–8.16

0.048*

RP group-univariate

 Positive surgical margin

2.41

1.00–5.78

0.050*

 Pathological N1 stage

1.97

0.87–4.46

0.105

 Pathological ≥T3 stage

2.17

0.65–7.32

0.210

 GS ≥8 at RP specimen

1.83

0.80–4.18

0.154

RP group-multivariate

 Positive surgical margin#

2.41

1.00–5.78

0.050*

  1. OR, Odds ratio; CI, confidence Interval; PSA, prostate specific antigen; GS, Gleason score; RP, radical prostatectomy; ExRT, external-beam radiotherapy; ADT, androgen deprivation treatment; PLI, pelvic lymphatic irradiation
  2. *indicates statistically significant data; + indicates borderline significant data
  3. #, for the RP group, positive surgical margin was the only significant risk factor predicting BF in multivariate analysis